Data / Form D filings / Quadrant Biosciences Inc
Quadrant Biosciences Inc: Form D filings
Quadrant Biosciences Inc, a biotechnology company in Syracuse, NY, filed 8 Form D notices with the SEC between 2015 and 2023. The latest, on November 2, 2023, reports an offering of $25.4 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 505 IRVING AVENUE, SUITE 3100 A-B, Syracuse, NY, 13210
- Phone
- (607) 227-4400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1651239
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 2, 2023 | New notice | $25,425,000 | $0 | $25,425,000 | 0 | Yet to occur | sec.gov |
| Aug 8, 2023 | New notice | $35,000,000 | $3,500,000 | $31,500,000 | 6 | Jul 27, 2023 | sec.gov |
| Jan 23, 2020 | New notice | $5,000,000 | $2,300,000 | $2,700,000 | 20 | Dec 3, 2019 | sec.gov |
| Jun 27, 2019 | New notice | $5,000,000 | $450,000 | $4,550,000 | 6 | Jun 12, 2019 | sec.gov |
| Dec 13, 2016 | New notice | $2,500,000 | $2,080,000 | $420,000 | 30 | Nov 30, 2016 | sec.gov |
| Apr 14, 2016 | Amendment | $5,000,000 | $3,602,450 | $1,397,550 | 36 | Aug 6, 2015 | sec.gov |
| Apr 13, 2016 | Amendment | $5,000,000 | $3,577,450 | $1,422,550 | 35 | Aug 6, 2015 | sec.gov |
| Aug 19, 2015 | New notice | $5,000,000 | $435,000 | $4,565,000 | 7 | Aug 6, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Erica Ash | Executive Officer | |
| James Croke | Executive Officer, Director | |
| Andrew Rock | Director | |
| Peter Cohen | Director | |
| Richard Bongo | Executive Officer, Director | |
| Nicholas Gianadda | Executive Officer | |
| Ira Fedder | Director | |
| Mary Ann Tyszko | Director | |
| Bryan Greene | Executive Officer | |
| Richard Uhlig | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Oct 30, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Quadrant Biosciences Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.